Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025

Description

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory method used to amplify and examine specific sequences of deoxyribonucleic acid or ribonucleic acid in a sample. Its primary function is to detect the presence of targeted genetic material, allowing for the identification of pathogens, genetic conditions, or mutations. This technique is extensively utilized in medical diagnostics due to its high sensitivity and accuracy in detecting infectious diseases, genetic disorders, and cancer-related markers.

The key product categories in PCR molecular diagnostics include instruments, reagents and consumables, and software. Instruments are devices or tools specifically designed for performing scientific, medical, or technical tasks and measurements. The technology includes real-time PCR, digital PCR, and conventional PCR methods, applied to various sample types such as blood, saliva, tissue, and urine. PCR molecular diagnostics are used across different applications, including infectious disease testing and oncology testing, and serve a range of end-users such as hospitals, diagnostic laboratories, and other healthcare facilities.

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction molecular diagnostics market statistics, including the polymerase chain reaction molecular diagnostics industry's global market size, regional shares, competitors with the polymerase chain reaction molecular diagnostics market share, detailed polymerase chain reaction molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. This polymerase chain reaction molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising demand for early disease detection, a growing prevalence of infectious diseases, heightened awareness of genetic disorders, increased adoption of point-of-care testing, and a higher incidence of chronic illnesses.

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing investments in molecular diagnostics, increasing need for rapid diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends expected during this period include advancements in diagnostic technologies, development of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, integration of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

The growing prevalence of infectious diseases is expected to drive the expansion of the polymerase chain reaction (PCR) molecular diagnostics market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person. The increasing prevalence of these diseases is largely due to the rise of antibiotic-resistant pathogens, which are more difficult to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. PCR molecular diagnostics improve the management of infectious diseases by offering rapid and accurate pathogen detection at the genetic level, enabling early diagnosis and targeted treatment. This enhances healthcare outcomes by promoting timely interventions, reducing the spread of infections, and improving patient care. For example, in November 2023, the Department of Health and Human Services, a U.S. government agency, reported an 11% increase in newly reported chronic hepatitis B cases in 2022 compared to 2021. As a result, the rising prevalence of infectious diseases is fueling the growth of the PCR molecular diagnostics market.

Leading companies in the polymerase chain reaction (PCR) molecular diagnostics market are focusing on developing cutting-edge solutions, such as benchtop instruments, to improve testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices small enough to fit on a workbench or table, designed for scientific, medical, or industrial testing and analysis. For example, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, introduced the QIAcuityDx Digital PCR System for clinical oncology testing. This system features fully automated, walk-away processing, integrating partitioning, thermocycling, and imaging into a single instrument. It provides absolute quantification of DNA and RNA in about two hours, with minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, making it adaptable to various clinical and laboratory requirements.

In May 2024, Bruker Corporation, a U.S.-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. This acquisition allows Bruker to enhance its presence in infectious disease diagnostics by broadening its molecular diagnostic capabilities and product portfolio, enabling it to better serve clinical laboratories and hospitals worldwide. ELITech Group SAS is an Italy-based in-vitro diagnostics company, specializing in polymerase chain reaction (PCR) molecular diagnostics.

Major players in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, and Zymo Research Corporation.

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polymerase chain reaction molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polymerase chain reaction molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35574

1. Executive Summary

2. Polymerase Chain Reaction Molecular Diagnostics Market Characteristics

3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies

4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Polymerase Chain Reaction Molecular Diagnostics Market Growth Rate Analysis
5.4. Global Polymerase Chain Reaction Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Polymerase Chain Reaction Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Polymerase Chain Reaction Molecular Diagnostics Total Addressable Market (TAM)

6. Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instrument
Reagents And Consumables
Software
6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction
Digital Polymerase Chain Reaction
Conventional Polymerase Chain Reaction
6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Samples
Saliva Samples
Tissue Samples
Urine Samples
6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease Testing
Oncology Testing
Other Applications
6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Other End Users
6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Polymerase Chain Reaction Systems
Digital Polymerase Chain Reaction Systems
Real-Time Polymerase Chain Reaction Systems
6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Kits
Polymerase Chain Reaction Enzymes
Polymerase Chain Reaction Primers And Probes
Polymerase Chain Reaction Master Mix
6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Analysis Software
Data Management Software

7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis

7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market

8.1. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction Molecular Diagnostics Market

9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview
9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction Molecular Diagnostics Market

10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction Molecular Diagnostics Market

11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview
11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction Molecular Diagnostics Market

12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market

13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market

14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview
14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market

15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction Molecular Diagnostics Market

16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction Molecular Diagnostics Market

17.1. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction Molecular Diagnostics Market

18.1. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction Molecular Diagnostics Market

19.1. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction Molecular Diagnostics Market

20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market

21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction Molecular Diagnostics Market

22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction Molecular Diagnostics Market

23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview
23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction Molecular Diagnostics Market

24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview
24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction Molecular Diagnostics Market

25.1. Canada Polymerase Chain Reaction Molecular Diagnostics Market Overview
25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction Molecular Diagnostics Market

26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview
26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market

27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market

28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview
28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction Molecular Diagnostics Market

29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview
29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles

30.1. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape
30.2. Polymerase Chain Reaction Molecular Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction Molecular Diagnostics Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings
31.2. Agilent Technologies Inc.
31.3. Grifols S.A.
31.4. Illumina Inc.
31.5. Endress + Hauser AG
31.6. bioMereieux SA
31.7. Sysmex Corporation
31.8. Bio-Rad Laboratories Inc.
31.9. QuidelOrtho Corporation
31.10. PerkinElmer
31.11. Eppendorf AG
31.12. Tecan Group
31.13. Takara Bio Inc.
31.14. Biocartis NV
31.15. Zymo Research Corporation

32. Global Polymerase Chain Reaction Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market

34. Recent Developments In The Polymerase Chain Reaction Molecular Diagnostics Market

35. Polymerase Chain Reaction Molecular Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer